Indian Immunologicals new facility in HyderabadIllustrative image – not actual.

Indian Immunologicals (IIL) has set up a facility in Hyderabad with an investment of Rs 250 crore to manufacture vaccines against infectious diseases of humans and animal health formulations.

Spread on 47 acre, at Phase III of Genome Valley in Karkapatla, Ranga Reddy District, it will help significantly expand the manufacturing capabilities.

The first phase of human vaccine facility can produce 8 million doses of human rabies vaccine. The animal health formulation facility is equipped to produce an estimated capacity of 300 million tablets, 100 million bolus, and 20 million vials of injectables.

← All latest storiesBack to top →